• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system.利用接合系统对耻垢分枝杆菌中卡那霉素和紫霉素抗性进行分子分析。
J Bacteriol. 1997 Aug;179(15):4795-801. doi: 10.1128/jb.179.15.4795-4801.1997.
2
Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.结核分枝杆菌对卷曲霉素、卡那霉素、阿米卡星和紫霉素交叉耐药性的分子分析
Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7. doi: 10.1128/AAC.49.8.3192-3197.2005.
3
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.tlyA基因突变赋予结核分枝杆菌卷曲霉素耐药性。
Antimicrob Agents Chemother. 2005 Feb;49(2):571-7. doi: 10.1128/AAC.49.2.571-577.2005.
4
Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.通过鉴定16S rRNA基因中的突变来检测耐卡那霉素结核分枝杆菌。
J Clin Microbiol. 1998 May;36(5):1220-5. doi: 10.1128/JCM.36.5.1220-1225.1998.
5
Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.结核分枝杆菌对卡那霉素、卷曲霉素和紫霉素的交叉耐药性。
Tubercle. 1977 Mar;58(1):29-34. doi: 10.1016/s0041-3879(77)80007-x.
6
Genetic and biochemical studies on drug-resistant mutants in Mycobacterium smegmatis.耻垢分枝杆菌耐药突变体的遗传学和生物化学研究。
Jpn J Microbiol. 1974 Nov;18(6):457-62. doi: 10.1111/j.1348-0421.1974.tb00834.x.
7
Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis.耻垢分枝杆菌紫霉素抗性突变体中30 S核糖体组分间的相互作用
Microbiol Immunol. 1979;23(7):595-604. doi: 10.1111/j.1348-0421.1979.tb00500.x.
8
Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.抗紫霉素耻垢分枝杆菌核糖体衍生的核心颗粒中对链霉素、卡那霉素、卷曲霉素和结核放线菌素的共同抗性定位
J Antibiot (Tokyo). 1976 Oct;29(10):1124-6. doi: 10.7164/antibiotics.29.1124.
9
Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.结核分枝杆菌中氨基糖苷类抗生素之间的交叉耐药关系。
J Gen Microbiol. 1975 Jun;88(2):269-74. doi: 10.1099/00221287-88-2-269.
10
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.将结核分枝杆菌临床分离株中rrs和eis启动子突变与对二线注射剂的表型药敏水平相关联。
Int J Mycobacteriol. 2016 Mar;5(1):1-6. doi: 10.1016/j.ijmyco.2015.09.001. Epub 2015 Oct 1.

引用本文的文献

1
Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification.分子诊断学的应用和进展:革新非结核分枝杆菌种和亚种鉴定。
Front Public Health. 2024 Jun 19;12:1410672. doi: 10.3389/fpubh.2024.1410672. eCollection 2024.
2
The structural basis for inhibition of ribosomal translocation by viomycin.威霉素抑制核糖体易位的结构基础。
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10271-10277. doi: 10.1073/pnas.2002888117. Epub 2020 Apr 27.
3
Inhibition of biofilm formation in Mycobacterium smegmatis by Parinari curatellifolia leaf extracts.柯拉叶提取物对耻垢分枝杆菌生物膜形成的抑制作用。
BMC Complement Altern Med. 2017 May 30;17(1):285. doi: 10.1186/s12906-017-1801-5.
4
In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.基于计算机模拟的高通量筛选以发现结核病治疗的新组合。
Antimicrob Agents Chemother. 2015 Sep;59(9):5664-74. doi: 10.1128/AAC.05148-14. Epub 2015 Jul 6.
5
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌临床分离株中与rrs A1401G突变相关的卷曲霉素耐药水平差异。
Antimicrob Agents Chemother. 2015 Jan;59(1):444-9. doi: 10.1128/AAC.04438-14. Epub 2014 Nov 10.
6
Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds.探索药用植物内生菌作为抗分枝杆菌化合物来源的潜力。
Microbiol Res. 2014 Jul-Aug;169(7-8):483-95. doi: 10.1016/j.micres.2013.12.009. Epub 2014 Jan 15.
7
Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.结核分枝杆菌中由于 whiB7 5' 非翻译区突变引起的氨基糖苷类交叉耐药性。
Antimicrob Agents Chemother. 2013 Apr;57(4):1857-65. doi: 10.1128/AAC.02191-12. Epub 2013 Feb 4.
8
Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP.利用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)和聚合酶链反应-单链构象多态性分析(PCR-SSCP)从耐多药结核菌株中快速鉴定广泛耐药和极端耐药结核病
Iran J Microbiol. 2012 Dec;4(4):165-70.
9
Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.焦磷酸测序法检测结核分枝杆菌临床分离株的一线和二线耐药性。
J Clin Microbiol. 2012 Jun;50(6):2026-33. doi: 10.1128/JCM.06664-11. Epub 2012 Mar 29.
10
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.与传统结核分枝杆菌药物敏感性试验相比,检测与一线和二线耐药相关的基因突变。
Antimicrob Agents Chemother. 2011 May;55(5):2032-41. doi: 10.1128/AAC.01550-10. Epub 2011 Feb 7.

本文引用的文献

1
Pleiotropic antibiotic resistance mutations associated with ribosomes and ribosomal subunits in Mycobacterium smegmatis.耻垢分枝杆菌中与核糖体及核糖体亚基相关的多效性抗生素抗性突变
Antimicrob Agents Chemother. 1974 Jul;6(1):46-53. doi: 10.1128/AAC.6.1.46.
2
Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon.利用具有单个rRNA操纵子的基因工程真细菌宿主将突变引入染色体rRNA基因。
Mol Microbiol. 1996 Dec;22(5):841-8. doi: 10.1046/j.1365-2958.1996.01532.x.
3
Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic.与一种氨基糖苷类抗生素复合的大肠杆菌16S核糖体RNA A位点的结构。
Science. 1996 Nov 22;274(5291):1367-71. doi: 10.1126/science.274.5291.1367.
4
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.结核分枝杆菌中利福平耐药性及rpoB基因突变
FEMS Microbiol Lett. 1996 Oct 15;144(1):103-8. doi: 10.1111/j.1574-6968.1996.tb08515.x.
5
Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.结核分枝杆菌对异烟肼敏感性所需的过氧化氢酶-过氧化物酶编码基因katG的特征分析。
J Bacteriol. 1993 Jul;175(13):4255-9. doi: 10.1128/jb.175.13.4255-4259.1993.
6
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.inhA,一种编码结核分枝杆菌中异烟肼和乙硫异烟胺靶点的基因。
Science. 1994 Jan 14;263(5144):227-30. doi: 10.1126/science.8284673.
7
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.结核分枝杆菌中利福平耐药性突变的检测
Lancet. 1993 Mar 13;341(8846):647-50. doi: 10.1016/0140-6736(93)90417-f.
8
The ribosomal RNA (rrn) operons of fast-growing mycobacteria: primary and secondary structures and their relation to rrn operons of pathogenic slow-growers.快速生长分枝杆菌的核糖体RNA(rrn)操纵子:一级和二级结构及其与致病性缓慢生长菌rrn操纵子的关系。
Microbiology (Reading). 1994 Oct;140 ( Pt 10):2829-40. doi: 10.1099/00221287-140-10-2829.
9
The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis.结核分枝杆菌单耐药和多耐药菌株中的rpsL基因与链霉素耐药性
Mol Microbiol. 1993 Nov;10(3):521-7. doi: 10.1111/j.1365-2958.1993.tb00924.x.
10
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.结核分枝杆菌中链霉素耐药性的分子基础:核糖体蛋白S12基因的改变及功能性16S核糖体RNA假结内的点突变
Mol Microbiol. 1993 Sep;9(6):1239-46. doi: 10.1111/j.1365-2958.1993.tb01253.x.

利用接合系统对耻垢分枝杆菌中卡那霉素和紫霉素抗性进行分子分析。

Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system.

作者信息

Taniguchi H, Chang B, Abe C, Nikaido Y, Mizuguchi Y, Yoshida S I

机构信息

Department of Microbiology, School of Medicine, University of Occupational and Environmental Health, Yahatanishiku, Kitakyusyu, Japan.

出版信息

J Bacteriol. 1997 Aug;179(15):4795-801. doi: 10.1128/jb.179.15.4795-4801.1997.

DOI:10.1128/jb.179.15.4795-4801.1997
PMID:9244267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC179326/
Abstract

We examined the molecular mechanisms of resistance to kanamycin and viomycin in Mycobacterium smegmatis. All of the M. smegmatis strains with high-level kanamycin resistance had a nucleotide substitution from A to G at position 1389 of the 16S rRNA gene (rrs). This position is equivalent to position 1408 of Escherichia coli, and mutation at this position is known to cause aminoglycoside resistance. Mutations from G to A or G to T at position 1473 of the M. smegmatis rrs gene were found in viomycin-resistant mutants which had been designated vicB mutants in our earlier studies. Using the M. smegmatis conjugation system, we confirmed that these mutations indeed contributed to kanamycin and viomycin resistance, and kanamycin susceptibility was dominant over resistance in a heterogenomic strain. Additional experiments showed that three of four Mycobacterium tuberculosis strains with high-level kanamycin resistance had a mutation from A to G at position 1400, which was equivalent to position 1389 of M. smegmatis.

摘要

我们研究了耻垢分枝杆菌对卡那霉素和紫霉素耐药的分子机制。所有对卡那霉素具有高水平耐药性的耻垢分枝杆菌菌株,其16S rRNA基因(rrs)的第1389位核苷酸发生了从A到G的替换。该位置相当于大肠杆菌的第1408位,已知此位置的突变会导致氨基糖苷类耐药。在我们早期研究中被指定为vicB突变体的紫霉素耐药突变体中,发现耻垢分枝杆菌rrs基因第1473位有从G到A或从G到T的突变。利用耻垢分枝杆菌接合系统,我们证实这些突变确实导致了对卡那霉素和紫霉素的耐药,并且在异基因组菌株中卡那霉素敏感性优于耐药性。进一步的实验表明,四株对卡那霉素具有高水平耐药性的结核分枝杆菌菌株中有三株在第1400位发生了从A到G的突变,该位置相当于耻垢分枝杆菌的第1389位。